daratumumab
janssen
['leukemia', ' dara ']
session 723 on hsct starts with dr. pietro merli giving an outstanding speech on long term outcomes of pediatric pts undergone alpha/beta t and b-depleted hla haploidentical hsct! #ash22 
MD @ClevelandClinic @unitorvergata | Lymphoma survivor#Resilient | MDS/AML/APL/Bone marrow failure syndromes| Member @TheEBMT_Trainee | Opinions are my own